3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
43
Leukemia, Myeloid, Acute
25
Recurrence
21
Lymphoma, Large B-Cell, Diffuse
12
Sarcoma
8
Neoplasms, Plasma Cell
5
Neoplasm Metastasis
5
Lymphoma
5
Glioblastoma
5
Ovarian Neoplasms
4
Neurofibrosarcoma
4
Neoplasms
4
Melanoma
4
Lymphoma, Non-Hodgkin
4
Endometrial Neoplasms
4
Colorectal Neoplasms
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma, B-Cell
3
Liposarcoma
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Waldenstrom Macroglobulinemia
2
Thymoma
2
Sarcoma, Alveolar Soft Part
2
Rhabdoid Tumor
2
Interventions
Dexamethasone
4
XENP 1595
2
Electroencephalography
2
selinexor
1
pomalidomide
1
ixazomib
1
fasudil
1
birtamimab
1
UE2343
1
Telemedicine
1
Tablets
1
Standard of Care
1
Rosiglitazone
1
Propofol
1
Positron-Emission Tomography
1
Methods
1
Melphalan
1
Mass Screening
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hypnosis
1
Hormones
1
Exercise
1
Ethanol
1
Donepezil
1
Cyclophosphamide
1
Control Groups
1
Calcium Dobesilate
1
Bortezomib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Alzheimer Disease
×
selinexor
×
Clear all
NCT04984330
2022-11-17
STARR
Weill Medical College of Cornell University
Phase EARLY_PHASE1
Withdrawn